Li Weng

Title: Innovations and Contributions of Li Weng in Biotechnology

Introduction

Li Weng, a prominent inventor based in Fremont, California, has made significant strides in the field of biotechnology with a remarkable portfolio of 22 patents. His inventions focus primarily on methods and compositions related to polynucleotide ligation, contributing valuable insights to sequence analysis and other applications.

Latest Patents

Li Weng's latest contributions include two noteworthy patents that deliver advanced methods for forming ligation products utilizing single-stranded polynucleotides. The first patent outlines innovative techniques that enable the formation of ligation products, which can play a crucial role in sequence analysis. These products are notable for comprising cell-free polynucleotides and can be employed in various applications. The second patent also emphasizes methods that form ligation products without the need for enriching single-stranded polynucleotides, further enhancing the ease of utilization in research and development settings.

Career Highlights

Throughout his career, Li Weng has worked with reputable organizations such as Accuragen Holdings Limited and Affymetrix, Inc., where he contributed to groundbreaking research and development in biotechnology. His role in these companies has solidified his reputation as a leading inventor in the field.

Collaborations

Li Weng has collaborated with notable colleagues, including Malek Faham and Jianbiao Zheng, fostering an environment of innovation and collective achievement in the biotechnology sector. These collaborations have not only enhanced his work but also contributed to advancements in their respective fields.

Conclusion

Li Weng’s extensive patent portfolio and career achievements illustrate his dedication to advancing biotechnology through innovative methods for polynucleotide ligation. His work is paving the way for future developments and applications in genetic research and molecular biology.